Go to Pathways list
Support our work
DONATE NOW

19th ESO-ESMO Masterclass in Clinical Oncology

Programme
MCO Coordinator: N Pavlidis, GR
ESO Chair: F. A. Peccatori, IT
ESMO Chair: F. Lordick, DE
Host Chair: E. Felip, ES
Scientific Advisors: C. Sessa, CH - R. A. Stahel, CH
 
The 19th ESO-ESMO Masterclass in Clinical Oncology is a closed event for selected participants. 
Applications for this edition are closed. Applications for the 2022 edition will open soon.

Aims, objectives and teaching format
The Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists focusing on multidisciplinarity. The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training.
It offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines. Participants will deliver case presentations within tumour boards and discuss them with an international faculty of top experts of each tumour type.
 
The Masterclass will be entirely in English and fluency in English is necessary for admission.
 
IMPORTANT INFORMATION
The Online Masterclass will be carried out in two different parts:
 
Part 1
Pre-recorded sessions will be made available from 5th February 2021 via this website, and will remain available for 1 month. You will be able to see all the sessions in your own time.
The pre-recorded sessions must be viewed before the Part 2 (Live weekend). 
When you finish watching a block on a specific tumour, please click on the link in each session and send us up to 3 questions related to the session. Some of your questions will be selected and answered during part 2 in the Q&A sessions. 
 
Part 2
Live sessions will be held on Saturday 6th and 7th March 2021.
During the live session, a lecture will be delivered for each main tumour group and will cover topics of interest for oncologists working in Western-Central Europe. Each lecture will be followed by a Q&A session using some of the questions that were sent in part 1.
After the Q&A session, participants will present their clinical cases, which will be discussed by the experts.

Accreditation
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 27 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
Application for CME recognition has been submitted to the European Society for Medical Oncology (ESMO) for ESMO-MORA accreditation, and 24 ESMO MORA cat. 1 credits have been granted to this event.
 
   ESCO - The ESO College
Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
 
Social media
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology
 
Should you have any queries, please do not hesitate to contact the event organisers:
Alice Ciocchini - Organisation and Programme - aciocchini@eso.net
Corinne Hall - Applications and Organisation - chall@eso.net
Mariachiara Deleo - e-ESO Assistant - mdeleo@eso.net
Francesca Marangoni - e-ESO Executive Manager -  fmarangoni@eso.net

The Masterclass in Clinical Oncology is an ESO-ESMO joint event 


The 2021 Masterclass is part of the Masterclass-Online Study Program in Advanced Oncology of the University of Ulm
 

Communication skills workshop organised by 
ABC Global Alliance

Programme

Expert: Nicholas Pavlidis

Expert: Florian Lordick

Parp inhibitors in BRCA mutation carriers

Expert: Giuseppe Curigliano

Q&A session

Expert: Giuseppe Curigliano

Expert: Olivia Pagani

Expert: Giancarlo Pruneri

Expert: Maria-João Cardoso

Expert: Olivia Pagani

Expert: Giancarlo Pruneri

Expert: Giuseppe Curigliano

Expert: Maria-João Cardoso

Use of systemic treatments in men with non metastatic prostate cancer

Expert: Karim Fizazi

Q&A session

Expert: Karim Fizazi

Expert: Xavier Maldonado

Expert: Ursula Vogl

Expert: Bertrand Tombal

Expert: Karim Fizazi

Expert: Bertrand Tombal

Expert: Xavier Maldonado

Expert: Ursula Vogl

Staging and iRECIST criteria

Expert: Thi Dan Linh Nguyen-Kim

Q&A session

Expert: Thi Dan Linh Nguyen-Kim

Expert: Enriqueta Felip

Expert: Fiona McDonald

The role of mutation testing in gynaecological cancer

Expert: Susana Banerjee

Q&A session

Expert: Jan Baptist Vermorken

Expert: Susana Banerjee

Expert: Thi Dan Linh Nguyen-Kim

Expert: Enriqueta Felip

Expert: Fiona McDonald

Expert: Jan Baptist Vermorken

Expert: Susana Banerjee

Biomarkers for precision treatment in gastrointestinal tumors

Expert: Hanneke van Laarhoven

Q&A session

Expert: Hanneke van Laarhoven

Expert: Sara De Dosso

Expert: Florian Lordick

Expert: Hanneke van Laarhoven

Expert: Sara De Dosso

Expert: Nicholas Pavlidis

Expert: Florian Lordick

Top